Research

Energy balance

No significant differences in readmission rates, BMI, and total weight loss were observed at 6, 12, and 18 months of follow-up between groups.

Long-term outcomes may not be significantly improved by preoperative AOM use.

StrongRefutesmedium confidence
At 6, 12, and 18 months of follow-up, readmission rates, BMI, and total weight loss showed no significant differences between groups.
Yonatan Lessing et al. · Bariatric Surgical Practice and Patient Care · 2025

Why this rating

Based on a retrospective analysis of a significant number of patients.

Source

The Role of Preoperative Consumption of Antiobesity Medications in Patients Undergoing Bariatric and Metabolic Surgery

Yonatan Lessing et al. · Bariatric Surgical Practice and Patient Care · 2025

DOI 10.1089/bari.2024.0038

cohort · n=169
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →